Biotech Values

[Mpower]

Thanks for posting RockRat. I too am a holder of LEAPS and some September calls. I expect the stock to do nicely in any approval scenario, trading well above $30 per share. That should make most of the longs here happy (for the time being).

The FDA is under pressure to approve mL by some big generic advocates, so I think they will do so, sooner rather than later. (w/in 30 days)